James Aloysius Brady is Director of Xeris Biopharma Holdings, Inc.. Currently has a direct ownership of 100,000 shares of XERS, which is worth approximately $468,000. The most recent transaction as insider was on Mar 28, 2025, when has been sold 100,000 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 100K
0% 3M change
n/a 12M change
Total Value Held $468,000

James Aloysius Brady Transaction History

Date Transaction Value Shares Traded Shares Held Form
Mar 28 2025
BUY
Grant, award, or other acquisition
-
100,000 Added 50.0%
100,000 Common Stock

Also insider at

VRNA
Verona Pharma plc Healthcare
JAB

James Aloysius Brady

Director
London, X0

Track Institutional and Insider Activities on XERS

Follow Xeris Biopharma Holdings, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells XERS shares.

Notify only if

Insider Trading

Get notified when an Xeris Biopharma Holdings, Inc. insider buys or sells XERS shares.

Notify only if

News

Receive news related to Xeris Biopharma Holdings, Inc.

Track Activities on XERS